Anupam Rasayan Delivers ₹44 Crore Q2 Profit; H1 FY26 Revenue at ₹1,229 Crore

Anupam Rasayan India Ltd announced its financial results for the quarter ended September 30, 2025, showing a strong year-on-year improvement across key financial parameters. The company reported a quarterly revenue of ₹731.3 crore, a sharp rise from ₹294 crore in the same period last year. 

Net profit for the quarter stood at ₹44 crore, compared to ₹16.6 crore a year ago, reflecting an improvement in operational efficiency and higher capacity utilisation.

Operational Highlights and Margins

The company’s Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) rose by 69% to ₹135.7 crore, up from ₹80.4 crore in the corresponding quarter last year. However, EBITDA margins narrowed to 18.6% from 27.4%, indicating cost pressures despite the rise in revenue. Management attributed the overall performance to a balanced demand recovery and continued focus on expanding its speciality chemicals portfolio.

First-Half Performance for FY26

For the first half of FY26, Anupam Rasayan’s consolidated revenue reached ₹1,229 crore, marking a 122% year-on-year growth. The company’s Managing Director, Anand Desai, stated that the second quarter was one of the strongest periods in recent times, with both operational and strategic progress. He highlighted the company’s focus on value-added products and long-term contracts, which have contributed to consistent revenue growth.

Market Performance of Anupam Rasayan India Shares

Following the announcement, the Anupam Rasayan India share price was recorded at ₹1,055 on the NSE as of 1:51 PM on October 17, 2025, down 6.42%. The company’s market capitalisation stood at ₹12,016 crore. Over the past year, the stock has traded between a high of ₹1,197 and a low of ₹601.

The stock currently holds a price-to-earnings (P/E) ratio of 97.3 and a book value of ₹281. It offers a dividend yield of 0.07%, with a return on capital employed (ROCE) of 7.33% and a return on equity (ROE) of 3.32%. 

Read More:Anupam Rasayan Signs 10-Year Letter of Intent Valued at $106 Million

Conclusion

Anupam Rasayan’s latest quarterly results indicate steady growth in revenue and profitability, supported by expansion in speciality chemical offerings. With a strong first-half performance and improving demand outlook, the company remains focused on sustaining growth through innovation and capacity enhancement in the coming quarters.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.